Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 268

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 268
---
2024, 88 common shares with a fair value of $127 were issued to providers of investor services in payment of services. |

| (viii) | On June 17, 2024, 162,970 common shares were issued in respect of RSU’s that had been fully vested. The RSU’s had a fair value of $243,003 at the time of issuance. |

| (ix) | During the period between June 20, 2024 and July 16, 2024, April 2023 Warrants, September 2023 Warrants and January 2024 Warrants were exercised into 306,172 common shares, for gross proceeds of $402,206. |

F-24 CLEARMIND MEDICINE INC. Notes to the Consolidated Financial Statements (Expressed in United States Dollars)

| 8. | Share               
 Capital (continued) |

| (xi) | On July 4, 2024, 64,617 common shares with a fair value of $98,218 were issued to providers of investor services in payment of services. |

| (xii) | During the period between July 4, 2024 and July 8, 2024, 134,868 common shares were issued in respect of RSU’s that had been fully vested. The RSU’s had a fair value of $256,252 at the time of issuance. |

| (xiii) | On August 12, 2024, April 2023 Warrants and September 2023 Warrants were exercised into 69,592 common shares, for gross proceeds of $74,999. |

| (xiv) | During the period between September 5, 2024 and September 19, 2024, 22,500 common shares were issued in respect of RSU’s that had been fully vested. The RSU’s had a fair value of $30,645 at the time of issuance. |

| (xv) | On October 31, 2024, 193,851 common shares with a fair value of $269,453 were issued to providers of investor services in payment of services. |

| (i) | On November 14, 2022, the Company completed an underwritten public offering of 38,462 common shares at a price to the public of $195.00 per share, for aggregate gross proceeds of $7.5 million, prior to deducting underwriting discounts and